HOB Biotech Group Corp.,Ltd
SSE:688656.SS
126.5 (CNY) • At close June 13, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 402.339 | 394.406 | 320.392 | 317.708 | 221.857 | 259.127 | 201.446 | 146.32 | 111.6 |
| Kosten van de omzet
| 145.156 | 149.413 | 118.136 | 98.546 | 76.4 | 82.733 | 59.158 | 44.305 | 38.343 |
| Brutowinst
| 257.183 | 244.993 | 202.256 | 219.161 | 145.457 | 176.394 | 142.289 | 102.014 | 73.257 |
| Brutowinstmarge
| 0.639 | 0.621 | 0.631 | 0.69 | 0.656 | 0.681 | 0.706 | 0.697 | 0.656 |
| Onderzoek- en ontwikkelingskosten
| 46.269 | 47.009 | 38.741 | 31.786 | 24.131 | 25.439 | 24.153 | 19.687 | 23.348 |
| Algemene en administratieve kosten
| 27.219 | 11.474 | 9.887 | 9.268 | 3.784 | 10.315 | 6.83 | 4.747 | 12.737 |
| Verkoop- en marketingkosten
| 31.898 | 93.879 | 78.657 | 68.05 | 50.081 | 54.718 | 42.365 | 35.631 | 31.262 |
| Verkoop-, algemene en administratieve kosten
| 59.117 | 105.572 | 88.544 | 77.318 | 53.865 | 65.033 | 49.195 | 40.379 | 43.999 |
| Overige kosten
| 110.415 | 0 | 32.224 | 23.648 | 15.355 | 15.137 | -2.518 | 0.24 | 1.066 |
| Bedrijfskosten
| 215.8 | 189.246 | 159.509 | 132.752 | 93.35 | 105.609 | 83.359 | 68.84 | 68.586 |
| Bedrijfsresultaat
| 41.383 | 55.843 | 47.566 | 97.523 | 65.099 | 70.054 | 49.164 | 24.587 | 3.146 |
| Bedrijfsresultaat ratio
| 0.103 | 0.142 | 0.148 | 0.307 | 0.293 | 0.27 | 0.244 | 0.168 | 0.028 |
| Totaal overige inkomsten en kosten netto
| -0.35 | 0.783 | -1.088 | 1.605 | 0.005 | 3.505 | -2.451 | 0.24 | -0.431 |
| Inkomen voor belasting
| 41.033 | 56.626 | 46.479 | 99.127 | 65.104 | 73.559 | 46.712 | 24.827 | 4.212 |
| Inkomen voor belasting ratio
| 0.102 | 0.144 | 0.145 | 0.312 | 0.293 | 0.284 | 0.232 | 0.17 | 0.038 |
| Belastingkosten
| 4.229 | 9.294 | 4.827 | 12.935 | 8.487 | 9.72 | 6.558 | 3.474 | -0.123 |
| Nettowinst
| 36.804 | 47.331 | 41.651 | 86.193 | 56.618 | 63.838 | 40.154 | 21.354 | 4.335 |
| Nettowinstmarge
| 0.091 | 0.12 | 0.13 | 0.271 | 0.255 | 0.246 | 0.199 | 0.146 | 0.039 |
| WPA (Winst Per Aandeel)
| 0.59 | 0.75 | 0.66 | 1.37 | 0.9 | 1.01 | 0.88 | 0.47 | 0.095 |
| Verwaterde WPA
| 0.59 | 0.74 | 0.66 | 1.37 | 0.9 | 1.01 | 0.88 | 0.47 | 0.095 |
| EBITDA
| 88.918 | 98.672 | 86.353 | 124.901 | 83.54 | 88.977 | 59.076 | 34.341 | 11.296 |
| EBITDA ratio
| 0.221 | 0.25 | 0.27 | 0.393 | 0.377 | 0.343 | 0.293 | 0.235 | 0.101 |